Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this talk, I will explore the impact of low-frequency mutations on the evolution of drug-resistant HIV, highlighting our breakthroughs with the AMPHEUS system and veSEQ pipeline for advanced genomic analyses. Our findings reveal crucial insights into the underestimated prevalence of transmitted NRTI resistance, underscoring the urgent need for enhanced surveillance in areas with high treatment failure rates.

David Bonsall is a pioneer of pathogen genomics, leads efforts to unravel the complexities of drug resistant HIV, leveraging cutting-edge technologies to inform global health strategies.